BioAge Labs, Inc.
BIOA
$4.38
$0.153.55%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -21.13M | -23.41M | -13.58M | -12.99M | -20.96M |
| Total Depreciation and Amortization | 47.00K | 38.00K | 49.00K | 33.00K | 41.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.36M | 2.21M | 1.69M | 1.99M | 7.89M |
| Change in Net Operating Assets | 13.58M | 6.23M | -3.94M | -4.70M | 4.53M |
| Cash from Operations | -5.14M | -14.93M | -15.78M | -15.67M | -8.50M |
| Capital Expenditure | -26.00K | -305.00K | -35.00K | -- | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 0.00 |
| Cash from Investing | -26.00K | -305.00K | -35.00K | -- | 0.00 |
| Total Debt Issued | -- | -- | -- | -- | 0.00 |
| Total Debt Repaid | -1.50M | -1.50M | -1.50M | -1.50M | -1.00M |
| Issuance of Common Stock | 27.65M | 194.18M | 422.00K | 3.00K | 4.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 0.00 | 542.00K | -- | 169.50M | -- |
| Repurchase of Preferred Stock | -- | -- | -40.00K | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.24M | -2.54M | -1.27M | -- | -13.00K |
| Cash from Financing | 24.90M | 190.68M | -2.39M | 168.00M | -1.01M |
| Foreign Exchange rate Adjustments | 137.00K | -58.00K | -17.00K | 19.00K | -65.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 19.88M | 175.39M | -18.22M | 152.35M | -9.58M |